PROCEPT BioRobotics (PRCT) Change in Cash (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Change in Cash data on file, last reported at -$40.9 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$40.9 million, down 133.25% year-over-year; the trailing twelve-month figure through Mar 2026 was -$70.6 million (down 177.86% YoY), and the FY2025 annual result was -$47.2 million, down 161.73% from the prior year.
• Change in Cash retreated to -$40.9 million in Q1 2026 per PRCT's latest filing, from -$7.8 million in the prior quarter.
• Over five years, Change in Cash peaked at $137.4 million in Q3 2023 and troughed at -$40.9 million in Q1 2023.
• A 5-year average of -$3.3 million and a median of -$17.3 million in 2024 frame the typical range for Change in Cash.
• On a YoY basis, Change in Cash climbed as much as 767.36% in 2023 and fell as far as 140.58% in 2023.
• A 5-year view of Change in Cash shows it stood at -$27.4 million in 2022, then decreased by 12.0% to -$30.6 million in 2023, then surged by 546.98% to $137.0 million in 2024, then plunged by 105.68% to -$7.8 million in 2025, then sank by 425.34% to -$40.9 million in 2026.
• Business Quant data shows PRCT's Change in Cash at -$40.9 million in Q1 2026, -$7.8 million in Q4 2025, and -$8.4 million in Q3 2025.